Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

164 trials

NCT07473154
Recruiting
Controlling Hyperactive Immunity With Long-lived Lymphocytes
Phase 1/2 · Germany, Spain, United Kingdom · 10 sites
Registry update: 19 Oct 2026
NCT07507201
Recruiting
Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
Early phase 1 · China · 1 site
Registry update: 2 Apr 2026
NCT07526350
Recruiting
MTS109 in Patients With Refractory Autoimmune Diseases
Early phase 1 · China · 1 site
Registry update: 30 Jun 2026
NCT06947473
Recruiting
Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
Phase 1/2 · China · 1 site
Registry update: 3 Mar 2026
NCT07402226
Recruiting
Systemic Sclerosis DIet for GastrointESTinal Symptoms
Not applicable · United States · 1 site
Registry update: 1 Jul 2026
NCT07087912
Recruiting
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Phase 4 · Brazil · 2 sites
Registry update: 20 Jul 2026
NCT07470151
Recruiting
Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
Not applicable · China · 1 site
Registry update: 13 Mar 2026
NCT05029336
Recruiting
Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
Phase 2 · United States · 1 site
Registry update: 14 Oct 2025
NCT07284797
Recruiting
A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases
Phase 1 · Australia · 1 site
Registry update: 3 Aug 2026
NCT07047690
Recruiting
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
Phase 2 · Bulgaria, Switzerland, Spain, France, Greece, Croatia, Italy, Poland, United States · 39 sites
Registry update: 31 Mar 2026
NCT07246096
Recruiting
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
Early phase 1 · China · 1 site
Registry update: 25 Feb 2026
NCT07256418
Recruiting
Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma
Not applicable · France · 1 site
Registry update: 29 Jan 2026
NCT07413341
Recruiting
A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
Phase 1 · China · 1 site
Registry update: 19 Oct 2026
NCT07251179
Recruiting
Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
Not applicable · France · 1 site
Registry update: 20 Aug 2026
NCT07355972
Recruiting
Safety, Efficacy and Cellular Metabolic Dynamics of CT1195E in Patients With Refractory / Progressive SSC
Early phase 1 · China · 1 site
Registry update: 21 Jan 2026
NCT07723872
Recruiting
Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease
Not applicable · Spain · 1 site
Registry update: 23 Jul 2026
NCT07295847
Recruiting
A Study of AZD0120 in Autoimmune Diseases
Phase 1/2 · Australia, Germany, Spain, United Kingdom, Sweden, United States · 23 sites
Registry update: 2 Nov 2026
NCT07315087
Recruiting
CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases
Phase 1 · China · 1 site
Registry update: 20 Jan 2026
NCT07360808
Recruiting
Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis
Not applicable · China · 2 sites
Registry update: 22 Jan 2026
NCT07301164
Recruiting
Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases
Early phase 1 · China · 1 site
Registry update: 23 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.